Ruling Out Acute Coronary Syndromes: Troponin Is Essential, as Is Clinical Assessment
In this issue of the Journal, Nestelberger et al.(6)aimed to validate, in an external large cohort of patients evaluated for suspected ACS in the ED, the performance of the extended algorithm in the prediction of short-term MACE (death, cardiac arrest, AMI [including the index event], cardiogenic sh...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 74; no. 7; pp. 855 - 857 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
20.08.2019
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0735-1097 1558-3597 1558-3597 |
DOI | 10.1016/j.jacc.2019.05.065 |
Cover
Summary: | In this issue of the Journal, Nestelberger et al.(6)aimed to validate, in an external large cohort of patients evaluated for suspected ACS in the ED, the performance of the extended algorithm in the prediction of short-term MACE (death, cardiac arrest, AMI [including the index event], cardiogenic shock, sustained ventricular arrhythmia, or high-grade atrioventricular block) or MACE + UA (angina with coronary revascularization within 24 h) and compare it with that of the ESC hs-cTn 0/1 h algorithm. Analyses were performed in 3,123 patients from the APACE (Advantageous Predictors of Acute Coronary Syndrome Evaluation) study with no ST-segment elevation, a clear final diagnosis, and two 0/1 hs-cTn determinations available. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 ObjectType-Article-3 |
ISSN: | 0735-1097 1558-3597 1558-3597 |
DOI: | 10.1016/j.jacc.2019.05.065 |